The role of intestinal glycosylation in determining individual responses to foods in inflammatory and neoplastic bowel diseases

References

• Mantis N. J., Frey A., Neutra M. R. Accessibility of glycolipid and oligosaccharide epitopes on rabbit villus and follicle‐associated epithelium. Am J Physiol Gastrointest Liver Physiol 2000; 278: G915–923
   PubMed Web of Science ®Google Scholar
• Campbell B. J., Yu L‐G., Rhodes J. M. Altered glycosylation in inflammatory bowel disease: A possible role in cancer development. Glycoconjugate Journal 2001; 18: 851–858
   PubMed Web of Science ®Google Scholar
• Campbell B. J., Hounsell E., Finnie I. A., Rhodes J. M. Direct demonstration of increased expression of Thomsen‐Friedenreich antigen (Galß1‐3GalNAc) by mucus in colon cancer and inflammatory bowel disease. J Clin Invest 1995; 95: 571–576
   PubMed Web of Science ®Google Scholar
• Yang J. M., Byrd J. C., Siddiki B. B., Chung Y. S., Okuno M., Sowa M., Kim Y. S., Matta K. L., Brockhausen I. Alterations of O‐glycan biosynthesis in human colon cancer tissues. Glycobiology 1994; 4: 873–884
   PubMed Web of Science ®Google Scholar
• Ju T., Cummings R. D. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3‐galactosyltransferase. Proc Natl Acad Sci U S A 2002; 99: 16613–16618
   PubMed Web of Science ®Google Scholar
• Rivinoja A., Kokkonen N., Kellokumpu I., Kellokumpu S. Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T‐antigen. J Cell Physiol 2006; 208: 167–174
   PubMedGoogle Scholar
• Campbell B. J., Rowe G., Leiper K., Rhodes J. M. Increasing the intra‐Golgi pH of cultured LS174T goblet‐differentiated cells mimics the decreased mucin sulphation and increased Thomsen‐Friedenreich antigen (Galβ1‐3GalNAcα‐) expression seen in colon cancer. Glycobiology 2001; 11: 385–393
   PubMedGoogle Scholar
• Bodger K., Halfvarson J., Dodson A. R., Campbell F., Wilson S., Lee R., Lindberg E., Järnerot G., Tysk C., Rhodes J. M. Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut 2006; 55: 973–977
   PubMedGoogle Scholar
• Ryder S. D., Jacyna M. R., Levi A. J., Rizzi P. M., Rhodes J. M. Eating peanuts increases rectal proliferation in individuals with mucosal expression of peanut lectin receptor. Gastroenterology 1998; 114: 44–49
   PubMed Web of Science ®Google Scholar
• Wang Q., Yu L‐G., Campbell B. J., Milton J. D., Rhodes J. M. Identification of intact peanut lectin in peripheral venous blood after peanut ingestion. Lancet 1998; 352: 1831–1832
   PubMed Web of Science ®Google Scholar
• Evans R. C., Fear S., Ashby D., Hackett A., Williams E., van der Vliet M., Dunstan F. D. J., Rhodes J. M. Diet and colorectal cancer: An investigation of the lectin/galactose hypothesis. Gastroenterology 2002; 122: 1784–1792
   PubMed Web of Science ®Google Scholar
• Key T. J., Fraser G. E., Thorogood M., Appleby P. N., Beral V., Reeves G., Burr M. L., Chang‐Claude J., Frentzel‐Beyme R., Kuzma J. W., et al. Mortality in vegetarians and nonvegetarians: Detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr 1999; 70: 516S–524S
   PubMed Web of Science ®Google Scholar
• Singh R., Subramanian S., Rhodes J. M., Campbell B. J. Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c‐Met and MAPK: Functional implications for disease‐associated glycosylation changes. Glycobiology 2006; 16: 594–601
   PubMed Web of Science ®Google Scholar
• Yu L‐G., Fernig D. G., White M. R. H., Spiller D. G., Appleton P., Evans R. C., Grierson I., Smith J. A., Davies H., Gerasimenko O. V., et al. Edible mushroom (Agaricus bisporus) lectin, which reversibly inhibits epithelial cell proliferation, blocks NLS‐dependent nuclear protein import. J Biol Chem 1999; 274: 4890–4899
   PubMed Web of Science ®Google Scholar
• Yu L. G., Andrews N., Weldon M., Gerasimenko O. V., Campbell B. J., Singh R., Grierson I., Petersen O. H., Rhodes J. M. An N‐terminal truncated form of Orp150 is a cytoplasmic ligand for the anti‐proliferative mushroom Agaricus bisporus lectin and is required for NLS‐dependent nuclear protein import. J Biol Chem 2002; 277: 24538–24545
   PubMedGoogle Scholar
• Yu L‐G., Packman L. C., Weldon M., Hamlett J., Rhodes J. M. Protein phosphatase 2A, a negative regulator of the ERK signalling pathway, is activated by tyrosine phosphorylation of PHAPI/pp32 in response to the anti‐proliferative lectin, jacalin. J Biol Chem 2004; 279: 41377–41383
   PubMed Web of Science ®Google Scholar
• Liu F. T., Rabinovich G. A. Galectins as modulators of tumour progression. Nat Rev Cancer 2005; 5: 29–41
   PubMed Web of Science ®Google Scholar
• Yu L‐G., Andrews N., Zhao Q., McKean D., Williams J. F., Connor L. J., Gerasimenko O. V., Hilkens J., Hirabayashi J., Kasai K., et al. Galectin‐3 interaction with Thomsen‐Friedenreich disaccharide on cancer‐associated MUC1 causes increased cancer cell–endothelial adhesion. J Biol Chem 2007; 282: 773–787
   PubMed Web of Science ®Google Scholar
• Martin H. M., Campbell B. J., Hart C. A., Mpofu C., Nayar M., Singh R., Englyst H., Williams H. F., Rhodes J. M. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127: 80–93
   PubMed Web of Science ®Google Scholar
• Swidsinski A., Ladhoff A., Pernthaler S., Swidsinski V., Loening‐Baucke M., Ortner J., Weber U., Hoffmann S., Schreiber., Dietel M., et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44–54
   PubMed Web of Science ®Google Scholar
• Darfeuille‐Michaud A., Boudeau J., Bulois P., Neut C., Glasser A. L., Barnich N., Bringer M. A., Swidsinki A., Beaugerie L., Colombel J. F. High prevalence of adherent‐invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412–421
   PubMed Web of Science ®Google Scholar
• Alpern J., Sasaki M., Sitaraman S., Rutherford R., Olejeme H., Cai Q., Klapproth J. Invasive E. coli strains are increased in Crohn's disease. Gastroenterology 2006; 130: A–362
   Google Scholar
• Kotlowski R., Bernstein C. N., Sepehri S., Krause D. O. High prevalence of Escherichia coli belonging to the B2 and D phylogenetic groups in inflammatory bowel disease. in press, Gut 2006
   Google Scholar